IFG Advisory LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CL) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 12,512 shares of the company’s stock, valued at approximately $312,000.
Other hedge funds have also modified their holdings of the company. Jacobi Capital Management LLC grew its stake in shares of Colgate-Palmolive by 125.5% in the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after buying an additional 803 shares in the last quarter. Krilogy Financial LLC grew its stake in shares of Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after buying an additional 289 shares in the last quarter. Captrust Financial Advisors acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at $122,000. AlphaMark Advisors LLC grew its stake in shares of Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after buying an additional 25 shares in the last quarter. Finally, Bruderman Asset Management LLC acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at $126,000. Institutional investors own 72.85% of the company’s stock.
Colgate-Palmolive (CL) traded down $0.21 during mid-day trading on Tuesday, reaching $69.98. The company had a trading volume of 550,768 shares, compared to its average volume of 4,332,276. Colgate-Palmolive has a 12-month low of $67.19 and a 12-month high of $77.91. The company has a current ratio of 0.47, a quick ratio of 0.34 and a debt-to-equity ratio of 24.42. The stock has a market cap of $61,256.62, a price-to-earnings ratio of 30.68, a P/E/G ratio of 2.58 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm had revenue of $3.89 billion for the quarter, compared to analyst estimates of $3.92 billion. During the same quarter in the prior year, the company earned $0.75 EPS. Colgate-Palmolive’s revenue was up 4.6% on a year-over-year basis. analysts anticipate that Colgate-Palmolive will post 3.18 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.29%. The ex-dividend date of this dividend is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is presently 70.18%.
A number of research analysts recently issued reports on CL shares. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 target price for the company in a report on Monday, October 23rd. Deutsche Bank initiated coverage on Colgate-Palmolive in a report on Wednesday, December 13th. They issued a “hold” rating and a $75.00 target price for the company. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target for the company in a report on Tuesday, December 19th. Finally, Stifel Nicolaus set a $73.00 target price on Colgate-Palmolive and gave the stock a “hold” rating in a research report on Sunday, October 29th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $77.71.
In related news, insider Jennifer Daniels sold 7,375 shares of the stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $73.18, for a total value of $539,702.50. Following the completion of the sale, the insider now directly owns 38,691 shares in the company, valued at approximately $2,831,407.38. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Vice Chairman Franck J. Moison sold 142,979 shares of the firm’s stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $70.09, for a total value of $10,021,398.11. Following the sale, the insider now owns 224,027 shares of the company’s stock, valued at $15,702,052.43. The disclosure for this sale can be found here. In the last three months, insiders have sold 318,451 shares of company stock worth $22,874,017. Corporate insiders own 1.02% of the company’s stock.
WARNING: “IFG Advisory LLC Buys Shares of 12,512 Colgate-Palmolive (CL)” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/13/ifg-advisory-llc-takes-312000-position-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.